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LETTERS
Our report highlights an 
alarming situation in Réunion 
Island. Reemergence of CS after the 
increase of early syphilis in women of 
childbearing age must be considered 
as a public health alert, especially 
in countries where health care is 
supposed to be effi cient. CS is easy 
to prevent with adequate screening 
of the mother and good follow-up of 
seropositive parturients.
The results of our study permitted 
reinforcement of the syphilis mass 
screening and awareness campaign 
regarding this sexually transmitted 
infection in the general population and 
medical corps. Although it is unrealistic 
to expect complete eradication of 
primary and secondary syphilis in 
communities, a minimal increase of CS 
rates should trigger reinforcement of 
these prevention policies. 
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To the Editor: I read with 
interest the article by Aguado et al. 
(1). I congratulate the authors for their 
high-quality research and would like 
to make 2 brief comments.
My fi rst point regards the 
mechanism by which methicillin-
susceptible Staphylococcus aureus 
(MSSA) with reduced susceptibility 
to vancomycin would also acquire 
decreased susceptibility to β-lactams. 
The authors “hypothesize that certain 
structural modifi cations might also 
occur in the cell wall of strains with 
high vancomycin MIC, including 
a thicker cell wall as it has been 
described in MRSA [methicillin-
resistant S. aureus].” In addition 
to cell wall thickening, possible 
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 Age, y 
Time of syphilis 
screening
 Duration of 
treatment, d 
 Presence and stage of 
disease
Positive serologic 





2008 16 >13 wk gestation 5 d BD Probable secondary 
syphilis at first trimester
 TPHA, VDRL, 
FTA-ABS
34 None 
2008 25 Unknown 2 d AD  NA TPHA, VDRL, 
FTA-ABS 
34 None 





2009 26 >13 wk gestation 17 d BD NA TPHA, VDRL, 
FTA-ABS 
31 Present
2009 18 >13 wk gestation 2 d BD NA TPHA, VDRL 32 Present
2009 22 >13 wk gestation 1 d BD NA TPHA, VDRL 32 Present
2009 37 After delivery 1 d AD NA TPHA, VDRL 38 None 
*BD, before delivery; TPHA, Treponema pallidum hemagglutination assay; VDRL, Venereal Disease Research Laboratory; FTA-ABS, fluorescent 
treponemal antibody absorption; AD, after delivery; NA, not applicable. 
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mechanisms could include reduction 
in autolysis (2,3) and in the cell wall 
content of penicillin binding protein 4 
(PBP4) (3). A study of MSSA isolates 
has shown a reduction in autolysis and 
in the bactericidal activity of oxacillin 
after development of intermediate 
vancomycin susceptibility (2). Lower 
content of PBP4 and decreased 
autolysis were reported in MRSA 
isolates after reduced susceptibility to 
vancomycin developed after exposure 
to this antimicrobial drug (3). 
Decreased PBP4 has been associated 
with reduced methicillin susceptibility 
in S. aureus (4).
Second, knowing whether the 
authors had the exact vancomycin 
MIC of the isolates by broth 
microdilution to compare with the 
Etest results would be interesting. In 
the article, they only state that “all 
99 MSSA strains were susceptible 
to vancomycin (MIC <2 μg/mL) by 
the broth microdilution method.” 
Although diffi cult to compare 
(because Etest dilution progression is 
arithmetic and broth microdilution is 
performed with a geometric dilution), 
some authors have found substantial 
differences between the vancomycin 
MIC results given by these 2 
methods (5). These differences could 
have major laboratory and clinical 
implications.
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In Response: We appreciate the 
comments by M. J. Mimica (1). We 
agree that mechanisms other than 
increased cell wall thickness, such 
as decreased autolysis, metabolic 
changes, and reduction in the cell wall 
content of penicillin binding protein 
4, characterize Staphylococcus aureus 
isolates, and they could explain this 
reduced susceptibility not only to 
vancomycin but also to β-lactam 
antimicrobial drugs. A recently 
published report by Holmes et al. (2) 
confi rms this hypothesis. That study 
showed that S. aureus vancomycin 
MIC >1.5 μg/mL, determined by Etest, 
was associated with a signifi cantly 
higher death rate for patients with 
methicillin-susceptible S. aureus 
bacteremia irrespective of the type of 
antimicrobial drug used.
Unfortunately, the vancomycin 
MIC determined by broth microdilution 
could not be compared with the Etest 
results because all our isolates had 
a MIC by broth microdilution that 
oscillated between 0.5 and 1.0 μg/
mL. No isolate had a MIC of 2 μg/
mL. In the study by Holmes et al., 
vancomycin MICs were higher by 
Etest than by broth microdilution (1); 
however, all isolates were considered 
vancomycin susceptible by Clinical 
and Laboratory Standards Institute 
broth microdilution methods. The 
authors pointed out that they also 
found that increased mortality 
rate was associated with increased 
broth microdilution MIC (data not 
shown), although the trend was not so 
prominent (2).
A prospective study would be 
required to specifi cally investigate 
the relationship between vancomycin 
MIC and outcome of S. aureus 
bacteremia. Our group is performing 
such a prospective study that we hope 
will enable us to shed light on this 
relevant topic.
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